Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors


Related Videos (117)

The Penn Center for Personalized Diagnostics performs large-scale, parallel DNA sequencing and chromosomal analysis to screen hematologic and solid tumors for a wide spectrum of mutations. This video offers a detailed rendering of the workflow for the genomic sequencing process from its initiation at DNA extraction, through the generation and sequencing of an amplicon library via one of two next-generation sequencing (NGS) panels (one for each tumor category) and finally, data analysis through the in-house bioinformatics pipeline wherein the variants are reviewed and interpreted for pathogenicity.


Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®